Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03004989Completed

Experiences of Participating in Return to Work Group Programmes

Role: lead

NCT02964156Not ApplicableCompleted

Effect of a Thin Customized Insole in RA

Role: lead

NCT02179307Not ApplicableCompleted

Individual Response to Different Volumes of Resistance Training

Role: collaborator

NCT00902005Completed

Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment

Role: lead

NCT01035125Not ApplicableCompleted

Effect of One Week Self-management Program in Patients With Fibromyalgia

Role: lead

All 5 trials loaded